A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution
Joint Authors
Javelot, Hervé
Heitzmann, Edwige
Michel, Bruno
Weiner, Luisa
Source
Issue
Vol. 2016, Issue 2016 (31 Dec. 2016), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2016-10-12
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Aripiprazole is reported to be a good clinical safety profile antipsychotic.
However, recent data suggest that the risk of tardive dyskinesia could be higher than initially thought.
We report the case of aripiprazole-induced tardive dyskinesia with dramatic evolution in a patient with several risk factors, including older age and exposure to antipsychotic over a period longer than six months.
This case and its dramatic evolution, associated with other cases recently published, suggest reconsidering the real risk of tardive dyskinesia associated with aripiprazole, particularly in the elderly.
American Psychological Association (APA)
Heitzmann, Edwige& Javelot, Hervé& Weiner, Luisa& Michel, Bruno. 2016. A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution. Case Reports in Psychiatry،Vol. 2016, no. 2016, pp.1-3.
https://search.emarefa.net/detail/BIM-1102507
Modern Language Association (MLA)
Heitzmann, Edwige…[et al.]. A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution. Case Reports in Psychiatry No. 2016 (2016), pp.1-3.
https://search.emarefa.net/detail/BIM-1102507
American Medical Association (AMA)
Heitzmann, Edwige& Javelot, Hervé& Weiner, Luisa& Michel, Bruno. A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution. Case Reports in Psychiatry. 2016. Vol. 2016, no. 2016, pp.1-3.
https://search.emarefa.net/detail/BIM-1102507
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1102507
